Geode Capital Management
BIAF icon

Geode Capital Management’s bioAffinity Technologies BIAF Stock Holding History

Geode Capital Management’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Buy
50,967
+2,674
+6% +$5.46K ﹤0.01% 4282
2026
Q1 		$185K Buy
48,293
+17,871
+59% +$28.9K ﹤0.01% 3936
2025
Q4 		$35.9K Buy
+30,422
New +$60.6K ﹤0.01% 4290
2025
Q3 		– Sell
-4,182
Closed -$36K – 4486
2025
Q2 		$36K Buy
4,182
+226
+6% +$2.58K ﹤0.01% 4276
2025
Q1 		$30.9K Buy
3,956
+638
+19% +$11.7K ﹤0.01% 4280
2024
Q4 		$93K Buy
3,318
+412
+14% +$16.6K ﹤0.01% 4114
2024
Q3 		$181K Buy
2,906
+586
+25% +$35.1K ﹤0.01% 3935
2024
Q2 		$150K Buy
2,320
+917
+65% +$63.5K ﹤0.01% 4009
2024
Q1 		$85K Buy
1,403
+177
+14% +$9.24K ﹤0.01% 4209
2023
Q4 		$54.8K Buy
+1,226
New +$52.5K ﹤0.01% 4325

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management's BIAF Position: Q2 2026 in Review

Geode Capital Management increased its bioAffinity Technologies (BIAF) stake by 5.5% in Q2 2026, buying an estimated $5.46K and bringing the position to 50,967 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4282.

Geode Capital Management first reported a position in BIAF in Q4 2023 and has held it in 10 quarters since. The position peaked at $185K in Q1 2026. 14 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Geode Capital Management held 50,967 shares of bioAffinity Technologies worth $41.4K as of Q2 2026.
  • Geode Capital Management bought 2,674 bioAffinity Technologies shares in Q2 2026, an estimated $5.46K.
  • bioAffinity Technologies made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4282 holding.
  • Geode Capital Management first reported a position in bioAffinity Technologies in Q4 2023 and has held it in 10 quarters since.
  • Geode Capital Management's bioAffinity Technologies position peaked at $185K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.